Atlas Trials

MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen

Clinical trial NCT00531336 · COMPLETED

Trial details

NCT number
NCT00531336
Sponsor
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Macular Degeneration
Start date
2006-07-01
Primary completion
2008-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.